STARHEALTH - Swing Trade Analysis with AI Signals
Back to ListSwing Trade Rating: 3.4
| Stock Code | STARHEALTH | Market Cap | 26,625 Cr. | Current Price | 453 ₹ | High / Low | 534 ₹ |
| Stock P/E | 59.7 | Book Value | 127 ₹ | Dividend Yield | 0.00 % | ROCE | 12.0 % |
| ROE | 9.37 % | Face Value | 10.0 ₹ | DMA 50 | 460 ₹ | DMA 200 | 460 ₹ |
| Chg in FII Hold | 0.56 % | Chg in DII Hold | -0.13 % | PAT Qtr | 128 Cr. | PAT Prev Qtr | 54.9 Cr. |
| RSI | 44.9 | MACD | -1.23 | Volume | 12,84,599 | Avg Vol 1Wk | 6,32,373 |
| Low price | 327 ₹ | High price | 534 ₹ | PEG Ratio | 1.59 | Debt to equity | 0.06 |
| 52w Index | 60.6 % | Qtr Profit Var | -40.4 % | EPS | 7.59 ₹ | Industry PE | 32.6 |
📊 STARHEALTH trades at ₹453, aligned with its 50DMA and 200DMA (₹460), showing neutral technical positioning. Indicators (RSI 44.9, MACD -1.23) suggest weak momentum. Fundamentals are mixed: strong revenue growth and low debt, but expensive valuation compared to industry PE, weak ROE/ROCE, and no dividend yield. This makes STARHEALTH a cautious swing trade candidate.
💡 Optimal Entry Price: Around ₹445–455 (near DMA support).
🔔 Exit Strategy if Holding: Consider exiting near ₹480–490 (short-term resistance) unless momentum strengthens further.
✅ Positive
- Quarterly PAT improved from ₹54.9 Cr. to ₹128 Cr.
- ROCE at 12% and ROE at 9.37% show moderate profitability.
- Debt-to-equity ratio of 0.06 indicates strong financial stability.
- FII holdings increased by 0.56%, showing foreign confidence.
⚠️ Limitation
- High P/E of 59.7 compared to industry PE of 32.6.
- Dividend yield is 0.00%, offering no income support.
- Quarterly profit variation of -40.4% indicates volatility.
- ROE and ROCE are relatively weak compared to peers.
📉 Company Negative News
- Price trading below recent highs, showing weak momentum.
- DII holdings decreased by 0.13%, showing reduced domestic confidence.
- Valuation is expensive compared to industry peers.
📈 Company Positive News
- Quarterly PAT more than doubled compared to previous quarter.
- Low debt enhances financial resilience.
- FII confidence reflected in increased holdings.
🏭 Industry
- Industry PE at 32.6, lower than STARHEALTH’s valuation.
- Health insurance sector benefits from rising demand and regulatory support.
- Margins remain under pressure due to claims volatility and competition.
🔎 Conclusion
STARHEALTH shows financial stability and improving profits but suffers from expensive valuation, weak technicals, and no dividend yield. It is a cautious swing trade candidate if entered near ₹445–455 with a target around ₹480–490. Risk management is essential due to valuation pressure and profit volatility.